Transcript Hedgehog Pathway Targeted by Vitamin E Therapy in NASH

Hedgehog Pathway
Targeted by Vitamin E
Therapy in NASH
AASLD
Washington, DC
November 03, 2013
DukeUniversityMedicalCenter
Cynthia D Guy1
Ayako Suzuki2
Manal F Abdelmalek1
James L Burchette1
Anna Mae Diehl1
Duke University Medical Center1
University of Arkansas for Medical Sciences2
for the NASH CRN
Background
 Hedgehog signaling promotes fibrogenic repair
 Hedgehog pathway is re-activated during NASH
?
 Ballooned hepatocytes  Hedgehog ligands  NASH
progression
 PIVENS Trial (NASH CRN)  Vitamin E improved NASH
Choi SS, Omenetti A, Syn WK, Diehl AM.
The role of Hedgehog signaling in fibrogenic repair.
Int J Biochem Cell Biol. 2011 43(2):238-244.
Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, Guy CD, Diehl AM.
Signals from dying hepatocytes trigger growth of liver progenitors.
Gut. 2010 May;59(5):655-65. doi: 10.1136/gut.2009.204354
Rangwala F, Guy CD, Lu J, Suzuki A, Burchette JL, Abdelmalek MF, Chen W, Diehl AM.
Increased production of sonic hedgehog by ballooned hepatocyte.
J Pathol. 2011 Jul;224(3):401-10. doi: 10.1002/path.2888. Epub 2011 May 5.
Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, Diehl AM; NASH CRN.
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.
Hepatology. 2012 Jun;55(6):1711-21. doi: 10.1002/hep.25559. Epub 2012 Apr 18.
DukeUniversityMedicalCenter
Hypothesis
Response to Vitamin E therapy
would be associated with
reduced Hedgehog pathway activity
in patients with NASH
DukeUniversityMedicalCenter
Design/Methods
Vitamin E
(n = 30)
Rx
Response (+)
(-)
Placebo
(n = 29)
(+)
(-)
Immunohistochemistry/Analysis
• #’s of Hh ligand producing cells
Shh+ cells
• #’s of ballooned hepatocytes
K8/18-negative/Ub+ cells
• #’s of Hh-responsive cells
Progenitors (gli-2+/sox-9+)
Myofibroblasts (gli-2+/α-SMA+)
DukeUniversityMedicalCenter
Results
Baseline clinical and histological characteristics of
the study population
Placebo
(N=29)
46±11
58.6%
82.8%
6.9%
35.5±7.1
58.6%
48.3%
74.9±37.0
49.4±25.4
4.9±3.9
Age, years
Gender, female %
Race, White %
Ethnicity, Hispanic %
BMI, kg/m2
HTN, %
IGT, %
Serum ALT, IU/L
Serum AST, IU/L
HOMA-IR
Histological scores
Hepatocyte ballooning, 17.2%; 34.5%; 48.3%
grade 0, 1, 2
Fibrosis, stage 0, 1, 2, 3
13.8%; 31.0%;
34.5%; 20.7%
Histological improvement, %**
27.6%
Vitamin E
(N=30)
47±10
60.0%
80.0%
20.0%
35.0±7.5
66.7%
56.7%
87.6±47.3
57.0±29.5
5.7±4.5
P-value#
0.60
0.91
0.79
0.13
0.80
0.52
0.52
0.26
0.30
0.46*
16.7%; 36.7%; 46.7%
0.98
6.7%; 40.0%;
30.0%; 23.3%
43.3%
0.75
0.21
#: p-values were from t-test or Chi-square test, except for * (Wilcoxon Rank-sum test).
**: defined by the PIVENS study design
BMI: body mass index, IGT: impaired glucose tolerance, HTN: systemic hypertension, HOMA-IR:
Homeostasis Model of Assessment - Insulin Resistance
DukeUniversityMedicalCenter
Results
Baseline Immunohistochemistry Data
Shh-positive ballooned hepatocytes,
cells/HPF
K8/18-negative or ubiquitin-positive foci,
cells/HPF
α-SMA-positive stain score, 0 to 4
gli-2+/sox-9+ stain score, 0 to 4
Placebo
(N=29)
Vitamin E
(N=30)
P-value#
4.5 ± 9.1
4.4 ± 8.0
0.60
2.8 ± 5.6
3.4 ± 6.3
0.73
2(1, 2.8)
1(1, 2)
2(2, 3)
2(1, 2)
0.34
0.23
#: p-values were from Wilcoxon Rank Sum tests.
Data were presented as mean ± SD for numeric variables and median (IQR) for ordinal variables.
DukeUniversityMedicalCenter
Results
 Regardless of the treatment arm, #’s of Shh+
hepatocytes correlated with
- K8/18-negative/Ub+ ballooned hepatocytes
(r2=0.47; P<0.001)
- AST (r2=0.15; P=0.002)
DukeUniversityMedicalCenter
Results
 After adjusting for baseline numbers of Shh+ and
K8/18-negative Ub+ cells, by multiple linear
regression analysis,
- Changes in #’s of Shh+ hepatocytes correlated with
changes in:
- AST (r2=0.75; P<0.001)
- ALT (r2=0.26, P<0.0001)
- H&E Ballooning (P=0.004)
- Trichrome Fibrosis stage (P=0.02)
- Ductular reaction
#’s of Shh-responsive progenitors (P=0.03)
#’s of α-SMA+ cells (P=0.10)
DukeUniversityMedicalCenter
Results
 Vitamin E group: greater reduction in
- Shh+ hepatocytes (P<0.05)
- K8/18-negative/Ub+ cells, foci (P=0.08)
 Multiple linear regression analysis, VitE group had
greater decrease in
- Shh+ hepatocytes (P<0.04)
- K8/18-negative/Ub+ (ballooned) hepatocytes
(P< 0.04)
DukeUniversityMedicalCenter
Results
 Regardless of the treatment arm, a
response to therapy (as defined by the
PIVENS trial design) was associated
with greater decrease in Shh+
hepatocytes than non-response
(P=0.007)
DukeUniversityMedicalCenter
A
B
Shh (brown) pretreatment VitE responder
(patient “X”) (400x)
Shh post-treatment VitE responder
(patient “X”) (400x)
C
K8/18 (brown)/Ub (red) pretreatment VitE
DukeUniversityMedicalCenter
responder
(patient “X”) (400x)
D
K8/18 (brown)/Ub (red) post-treatment VitE
responder (patient “X”) (400x)
IHC: gli-2 (red), sox-9 (blue)
DukeUniversityMedicalCenter
α-SMA (brown)
A
IHC: gli-2 (red), sox-9 (blue)
α-SMA (brown)
gli-2/sox-9/α-SMA pretreatment VitE responder
(patient “X”) portal tract (400x)
gli-2/sox-9/α-SMA pretreatment VitE responder
(patient “X) zone 3 (400x)
C
D
gli-2/sox-9/α-SMA post-treatment VitE
responder (patient “X”) portal tract (400x)
gli-2/sox-9/α-SMA post-treatment VitE
responder (patient “X”) zone 3 (400x)
B
Conclusions
 Reduction of NASH injury with

vitamin E Rx  decreased:
- hepatocyte ballooning
- production of Hh ligand
- #’s of Hh-responsive progenitors
Inhibition of Hh pathway activity was
associated with improved:
- liver injury
- fibrosis stage
- treatment response
DukeUniversityMedicalCenter
Illustrative Model
Ballooning
Dying hepatocyte
Progenitors
Lipotoxicity
Quiescent
HSC
Hedgehog
Ligands
Myofibroblasts
Ductular
Reaction
DukeUniversityMedicalCenter
Speculation
 Inhibiting Hedgehog and/or its effectors might
be a new treatment approach for NASH
- Smoothened antagonist
Mouse
improves NASH*
models
- Antagonists of Osteopontin
(fibrogenic Hedgehog target
gene) improve NASH**
*Hirsova P, Ibrahim Sh, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver
injury in a mouse model of nonalcoholic steatohepatitis. PLoS One. 2013 Jul 22;8(7):e70599doi:
10.1371/journal.pone.0070599. Print 2013.
** Syn WK, Choi SS, Liakou E, Karaca GF, Agboola KM et al. Osteopontin is Induced by Hedgehog
Pathway Activation and Promotes Fibrosis Progression in Nonalcoholic Steatohepatitis. Hepatology.
2011;53:106-115.
DukeUniversityMedicalCenter
NASH CRN Credits
Principal Investigators
Data Coordinating Center (JHU)
Pathologists
• Patricia Belt
Adult Centers
• Elizabeth Brunt (Wash U)
• Jeanne Clark
• CCF/CWRU: Arthur McCullough • David Kleiner (NCI)
• Michele Donithan
• CU: Joel Lavine
• Cynthia Behling (UCSD)
• Erin Hallinan
• DUKE: Anna Mae Diehl
• Melissa Contos (VCU)
• Milana Isaacson
• IU: Naga Chalasani
• Oscar Cummings (IU)
• SLU: Brent Tetri
• Linda Ferrell, Ryann Gill (UCSF) • Patrick May
• Laura Miriel
• UCSD: Rohit Loomba
• Cynthia Guy (DUKE)
• James Tonascia
• UCSF: Norah Terrault
• Rish Pai (CWRU)
• Aynur Ünalp-Arida
• VMMC: Kris Kowdley
• Matthew Yeh (UW)
• Mark Van Natta
• VCU: Arun Sanyal
• Ivana Vaughn
• Laura Wilson
Pediatric Centers
• Katherine Yates
• BCM: Sarah Barlow
NIDDK Program Official
• CINC: Stavra Xanthakos
• Averell Sherker
• CU: Joel Lavine
NIDDK Project Scientist
• IU: Jean Molleston
• Edward Doo
• JHU: Ann Scheimann
• NWU: Peter Whitington
• SLU: Ajay Jain
• UCSD: Jeffrey Schwimmer
• UCSF: Philip Rosenthal
• UW: Karen Murray
DukeUniversityMedicalCenter
Thank you
 Anna Mae Diehl’s Lab
Chief, Division of Gastroenterology and Hepatology,
Department of Medicine, Duke University Medical Center
Steve Choi
Gregory Michelotti
Marzena-Swiderska-Syn
Guanhua Xie
Gamze F. Karaca
Leandi Kruger
Thiago D Pereira
Mariana V Machado
Katherine Garman
Cynthia Moylan
Jerome Boussier
W. Carl Stone
DukeUniversityMedicalCenter
Anna Mae Diehl
Ayako Suzuki
Manal Abdelmalek
Jim Burchette
Additional slides
DukeUniversityMedicalCenter
Results
Changes in serum AST
150
100
50
0
-50
y = 1.3852x - 9.8841
R=0.16, p=0.002
-100
-150
-40
-20
0
20
Changes in Shh+ BH
DukeUniversityMedicalCenter
40
Partial residual of changes
in serum AST
Correlation between changes in Shh+
ballooned hepatocytes and changes in serum AST.
50
40
30
20
10
0
-10
-20
-100
y = 0.248x + 1.8887
R=0.75, p<0.0001
0
100
200
Partial residual of changes in
Shh+ BH
Results
Correlation between changes in Shh+ ballooned hepatocytes
and changes in K8/18-negative hepatocytes/ubiquitin-positive foci.
Figure legend: The partial regression plot shows the relationship between the
changes in Shh+ ballooned hepatocytes and the changes in K8/18-negative hepatocytes/ubiquitin-positive foci after adjusting for baseline values.
The horizontal axis is partial residual of the changes in K8/18-negative/ubiquitin-positive hepatocytes while the vertical axis is partial residual of
the changes in Shh+ ballooned hepatocytes. Solid line is a regression line, and dotted curve lines depict 95% confidence curve.
There was significant positive correlation (p=0.0039).
Results
Correlation between changes in Shh+
ballooned hepatocytes and changes in serum AST.
Figure legend: The partial regression plot shows the relationship between the changes in Shh+ ballooned hepatocytes and
the changes in serum AST after adjusting for baseline values. The horizontal axis is partial residual of the changes in Shh+
ballooned hepatocytes while the vertical axis is partial residual of the changes in serum AST. Solid line is a regression line,
and dotted curve lines depict 95% confidence curve. There was significant positive correlation (p<0.0001).
Results
Comparison of changes in immunohistochemical data with and
without adjusting for baseline values: Placebo vs. Vitamin E groups.
Placebo
(N=29)
Vitamin
E
(N=30)
pvalue
Shh-positive ballooned
hepatocytes, cells/HPF
1.2±10.7
-3.0±8.3
0.048
-4.4±2.1
0.037
K8/18 -negative cells or
ubiquitin-positive foci/HPF
0.2±1.4
-2.9±1.3
0.082
-2.6±1.2
0.037
α-SMA-positive stain score,
Grade 0 to 4
0 (0, 0)
0 (-1, 0)
0.097
1.8[0.6,
5.6]
0.34
gli-2/sox-9-positive stain score,
Grade 0 to 4
0 (0, 0)
0 (-1, 0)
0.068
1.7[0.5,
5.5]
0.36
Changes in:
β±SE/
OR[95%C
pI]
value
Data were presented as mean ± SD for numeric variables and median (IQR) for ordinal variables.
#: Wilcoxon Rank-Sum tests
DukeUniversityMedicalCenter